GSK: expenditure on research and development 2006-2022

Published by
Matej Mikulic,
Mar 21, 2023
GSK (GlaxoSmithKline) plc is a global pharmaceutical and biotech company, headquartered in London. This statistic shows the expenditure on research and development of pharmaceutical company GSK from 2006 to 2022. In 2022, the company invested around 5.5 billion British pounds in research and development.

GSK's expenditure on research and development from 2006 to 2022 (in million British pounds)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2023

Region

Worldwide

Survey time period

2006 to 2022

Supplementary notes

This statistic was assembled from several editions of the GSK Annual Report.
* Restated.

Citation formats
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you

Overview

7

Drug prices and consumer behavior

5

Advertising expenditures

4

Further related statistics

14

Further Content: You might find this interesting as well

Statistics

Topics

GlaxoSmithKline Pharmaceuticals Limited IndiaGlobal pharmaceutical industrySanofiPfizerJohnson & Johnson
Statista Accounts: Access All Statistics. Starting from $588 USD / Year
Learn more about how Statista can support your business.
Menu